These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 28665687)
1. Elevated Expression of ERCC6 Confers Resistance to 5-Fluorouracil and Is Associated with Poor Patient Survival in Colorectal Cancer. Zhao Z; Zhang G; Li W DNA Cell Biol; 2017 Sep; 36(9):781-786. PubMed ID: 28665687 [TBL] [Abstract][Full Text] [Related]
2. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer. Zhang Y; Talmon G; Wang J Cell Death Dis; 2015 Aug; 6(8):e1845. PubMed ID: 26247730 [TBL] [Abstract][Full Text] [Related]
4. PFKP is upregulated in 5-fluorouracil-resistant patients and suppresses the antitumor activity of 5-fluorouracil in colorectal cancer Deng L; Zhao Y; Liu W J Chemother; 2024 Sep; 36(5):422-434. PubMed ID: 38044588 [TBL] [Abstract][Full Text] [Related]
5. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer. Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway. Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955 [TBL] [Abstract][Full Text] [Related]
9. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells. Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer. Lee JH; Lee SW Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570 [TBL] [Abstract][Full Text] [Related]
11. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584 [TBL] [Abstract][Full Text] [Related]
12. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1. Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. de Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; Reichelt W; Beigi M; Clausen OP; Galteland E; Stokke T Int J Oncol; 2004 May; 24(5):1279-88. PubMed ID: 15067352 [TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31. Li J; Li X; Cen C; Ai X; Lin C; Hu G Oncol Rep; 2018 Jan; 39(1):217-226. PubMed ID: 29115526 [TBL] [Abstract][Full Text] [Related]
15. Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer. Hu H; Wang M; Guan X; Yuan Z; Liu Z; Zou C; Wang G; Gao X; Wang X Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29371412 [TBL] [Abstract][Full Text] [Related]
16. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy. Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767 [TBL] [Abstract][Full Text] [Related]
17. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade. Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806 [TBL] [Abstract][Full Text] [Related]
18. Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil. Liu T; Wang X; Hu W; Fang Z; Jin Y; Fang X; Miao QR Neoplasia; 2019 Jun; 21(6):557-570. PubMed ID: 31042625 [TBL] [Abstract][Full Text] [Related]
19. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells. Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer. Blondy S; Talbot H; Saada S; Christou N; Battu S; Pannequin J; Jauberteau MO; Lalloué F; Verdier M; Mathonnet M; Perraud A J Cell Mol Med; 2021 Jan; 25(1):47-60. PubMed ID: 33325631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]